The Centers for Disease Control and Prevention (CDC) awarded a $41,290,502.86 firm-fixed-price definitive contract to Verily Life Sciences LLC, doing business as G L S, for wastewater surveillance testing. The contract has an ultimate completion date of August 6, 2026 and was awarded on January 12, 2024 without any set-aside designation. Verily Life Sciences, a subsidiary of Alphabet Inc., specializes in collecting, organizing, and activating health data, and has provided wastewater surveillance testing services to federal agencies to support public health monitoring efforts related to COVID-19 and monkeypox, as well as preparedness for future public health emergencies. This contract will support the CDC's disease surveillance programs and assist in monitoring disease spread within communities, contributing to the nation's preparedness for current and future public health challenges.
Generated 12/22/24, 12:13 AM